Hers vs SnagRx: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher
Reviewed & updated · Cites primary sources (FDA, NEJM, CMS) · Not medical advice
54 providers verified independently·Independent researchHow we rank →

Short answer: Hers scores higher on our rubric, 5.3/10 against 4.5/10. Full reasoning, pricing and the cases where the other one wins are below.

Hers beats SnagRx overall, scoring 5.3/10 vs 4.5/10. Published pricing is not a like-for-like monthly comparison: Hers is $188 first month, then $298/mo; SnagRx is published $99/mo; total not verified. Choose Hers for women who want a female-focused platform and can budget at least $188 initially and $298/mo ongoing for a $149 medication path. Choose SnagRx for price-first buyers comfortable prepaying a multi-month plan from the company that operates embody, our most-converted partner, and who will verify the consult-fee clause in the terms before checkout.

A side-by-side look at Hers and SnagRx to help you decide. We compare them on:

  • Starting price per month
  • Our overall score, out of 10
  • Medication type, brand-name or compounded
  • Whether they accept insurance
  • Who each one is best for
Higher Rated

Hers

#44 of 54
5.3/10

The women's health arm of Hims & Hers Health (NYSE: HIMS). Hers lists Wegovy pill, Foundayo, and Ozempic pill medication from $149, a Wegovy pen from $199, Zepbound from $299, and compounded options. Wegovy and Foundayo carry FDA approval for weight management. Ozempic is FDA approved for type 2 diabetes and is prescribed off label for weight loss. A required Weight Loss Membership adds $39 in month one and $149/mo thereafter, so the all-in floor for a $149 medication path is $188 initially and $298/mo ongoing; exact product and dose prices vary.

Visit Hers

SnagRx

#50 of 54
4.5/10

SnagRx is a cash-pay compounded GLP-1 storefront operated by Modern Metabolic Medicine, Inc., the same company behind Embody and RodeoMeds. Its semaglutide and tirzepatide pages publish a full four-tier grid above the buy button: semaglutide at $99/mo month-to-month, $89 on three months, $79 on six and $69 on a twelve-month plan billed $828 upfront, and tirzepatide at $149, $139, $129 and $119, with multi-month plans billed once and auto-renewing for the same length. The homepage leads the 12-month rates against struck-through comparison prices of $299 and $399. Read the refund policy before the price: payment is final and non-refundable at the moment of purchase, and multi-month plans are non-refundable in whole and in part, so the grid is a committed spend rather than a monthly bill. The terms also refer to non-refundable medical consult fees and warn the final charge may vary by medication and pharmacy. Shipping is free at a stated 1-2 days. Four partner pharmacies are named in the footer with addresses, and the terms allow a prescription to be transferred among them. The site launched in January 2026 and its Trustpilot profile carries 2 reviews at 3.8 stars (checked 2026-09-03).

Visit SnagRx
FeatureHersSnagRx
Our Score5.3/104.5/10
Headline Price$188 first month, then $298/mopublished $99/mo; total not verified
Medication TypeBothCompounded
Insurance AcceptedNoNo
Best ForWomen who want a female-focused platform and can budget at least $188 initially and $298/mo ongoing for a $149 medication path
Price-first buyers comfortable prepaying a multi-month plan from the company that operates Embody, our most-converted partner, and who will verify the consult-fee clause in the terms before checkout
Watch out forPending federal enforcement against the parent company: on July 29, 2026 the FTC, joined by Utah and by California acting through Los Angeles County Counsel, sued Hims & Hers Health, Inc. in the Northern District of California over subscription billing, cancellation friction and sharing consumer health information with advertising platforms. The case status is Pending and these are allegations, not findings (checked 2026-09-03).
Almost no independent review record. The Trustpilot profile, claimed in June 2026, carries 2 reviews at 3.8, so the '125k+ Happy Customers' banner on the homepage cannot be corroborated anywhere (checked 2026-09-03)
Ranking#44#50
Get startedVisit HersVisit SnagRx

Pros & Cons Compared

Hers

Pros

  • +Brand-name paths include Wegovy pill, Foundayo, and Ozempic pill medication from $149 and a Wegovy pen from $199. Wegovy and Foundayo carry FDA approval for weight management, Ozempic is approved for type 2 diabetes and is used off label here. With the required membership, a $149 medication path totals $188 initially and $298/mo ongoing
  • +Zepbound access via the Lilly/Hims-Hers partnership announced 2026
  • +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
  • +Broader women's health platform, integrates weight loss with hormonal, skin, and wellness services

Cons

  • Pending federal enforcement against the parent company: on July 29, 2026 the FTC, joined by Utah and by California acting through Los Angeles County Counsel, sued Hims & Hers Health, Inc. in the Northern District of California over subscription billing, cancellation friction and sharing consumer health information with advertising platforms. The case status is Pending and these are allegations, not findings (checked 2026-09-03).
  • Every medication figure excludes the required Weight Loss Membership ($39 first month, then $149/mo); exact product and dose prices can increase the total above the $188/$298 floor
  • Support runs at big-platform scale, fine for routine refills, less personal if you want high-touch care
  • Compounded pricing starts at $199/mo with stepped pricing at higher doses, budget for the dose you'll end up on, not the entry dose
  • Zepbound medication starts at $299 before the required membership; that path totals $338 in month one and at least $448/mo ongoing, with exact dose pricing potentially higher

SnagRx

Pros

  • +A published plan grid with locked flat pricing across doses, on the product pages rather than buried in the terms: semaglutide at $99, $89, $79 and $69/mo across one, three, six and twelve months, and tirzepatide at $149, $139, $129 and $119; a consult-fee clause and a price-variance clause in the terms remain the unresolved costs
  • +Names four partner pharmacies in its footer with full street addresses and phone numbers, Red Rock Compounding, Health Warehouse, Precision Medicine and Triad Rx, which most competitors do not do
  • +Free 1-2 day shipping with a stated one-day turnaround from intake to a written prescription
  • +The site markets a locked medication rate with no monthly membership and publishes a separate refund policy; its terms still leave a possible medical consult fee unresolved
  • +States service in all 50 states plus Washington D.C. in its terms, and names the two carve-outs on the homepage: no service in Louisiana, and Nebraska limited to patients 19 and over

Cons

  • Almost no independent review record. The Trustpilot profile, claimed in June 2026, carries 2 reviews at 3.8, so the '125k+ Happy Customers' banner on the homepage cannot be corroborated anywhere (checked 2026-09-03)
  • The homepage leads the 12-month rate ($69/mo, billed $828 once) under a countdown timer that re-seeds on each visit instead of counting down to a dated deadline, while the month-to-month rate is $99
  • 'Cancel Anytime' appears three times on the homepage, but the refund policy requires a cancellation at least 72 hours before the next billing date to stop that charge, and cancelling only halts future billing. It returns nothing you have already paid
  • 'No Hidden Fees' is contradicted by the terms, which refer to medical consult fees that are not refundable
  • Payment is final and non-refundable at the moment of purchase, before a clinician has read your intake, and multi-month plans are sold as a single indivisible purchase that is non-refundable in whole and in part. The one exception is a provider ruling you medically ineligible, and even then the value of services already rendered is deducted
  • No individual clinician is named. SnagRx says in a homepage FAQ that it has a medical director who is a practising physician, and its footer names OpenLoop Health as the treating network, but no provider name, licence number, lab requirement or video-visit detail is published
  • Shares its operating entity with Embody and RodeoMeds. Neither SnagRx nor Embody discloses the relationship on its own site, so a shopper comparing them would not know they are one company
  • Cash-pay only, no insurance billing and no prior-authorisation help

Our Verdict

Hers edges out SnagRx with a score of 5.3/10 vs 4.5/10. Published pricing is not a like-for-like monthly comparison: Hers is $188 first month, then $298/mo; SnagRx is published $99/mo; total not verified. Hers offers both brand-name and compounded medications, giving you more flexibility.

Related comparisons

More head-to-head comparisons involving Hers and SnagRx.

Not comparing, just asking? Quick answers to the most-asked GLP-1 questions →

Not sure which one is right for you?

Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.

Still working out whether either one is above board? We check that separately: is Hers legit, with the verification evidence behind each answer.